Effect of curcumin on the diversity of gut microbiota in ovariectomized rats

Nutrients

Volumn 9, Issue 10, 2017, Pages

  Zhang, Zhiguo ^a   Chen, Yanjing ^a   Xiang, Lihua ^a   Wang, Zhen ^a   Xiao, Gary Guishan ^b   Hu, Jingqing ^a  

^a INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^b DALIAN UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

Curcumin; Gut microbiota; Menopause; Ovariectomy; Rat

Indexed keywords

CURCUMIN; DNA 16S; ESTRADIOL; BACTERIAL DNA; RNA 16S;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTEROIDETES; CONTROLLED STUDY; CURCUMA LONGA; ELECTROCHEMILUMINESCENCE; ESTROGEN DEFICIENCY; EXIGUOBACTERIUM; FEMALE; FIRMICUTES; HELICOBACTER; HIGH THROUGHPUT SEQUENCING; IMMUNOASSAY; INTESTINE FLORA; MICROBIAL DIVERSITY; NONHUMAN; OBESITY; OVARIECTOMY; POLYMERASE CHAIN REACTION; PSEUDOMONAS; QUALITY CONTROL; RAT; SERRATIA; SHEWANELLA; WEIGHT GAIN; ANIMAL; BACTERIUM; BLOOD; BODY WEIGHT GAIN; CHEMISTRY; CLASSIFICATION; DNA SEQUENCE; DRUG EFFECT; FECES; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; ORGAN SIZE; UTERUS; WISTAR RAT;

ANIMALS; BACTERIA; CURCUMIN; DNA, BACTERIAL; ESTRADIOL; FECES; FEMALE; GASTROINTESTINAL MICROBIOME; MODELS, ANIMAL; ORGAN SIZE; OVARIECTOMY; RATS; RATS, WISTAR; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA; UTERUS; WEIGHT GAIN;

EID: 85032257760     PISSN: None     EISSN: 20726643     Source Type: Journal    
DOI: 10.3390/nu9101146     Document Type: Article

References (40)

1. Oppermann,K.; Fuchs, S.C.; Bastos,C.A.; Spritzer, P.M. Physical, psychological, andmenopause-related symptoms and minor psychiatric disorders in a community-based sample of brazilian premenopausal, perimenopausal, and postmenopausal women. Menopause 2012, 19, 355-360.
2. Boschitsch, E.P.; Durchschlag, E.; Dimai, H.P. Age-related prevalence of osteoporosis and fragility fractures:Real-world data from an austrian menopause and osteoporosis clinic. Climacteric 2017, 20, 157-163.
3. Goncalves, J.T.; Silveira, M.F.; Campos, M.C.; Costa, L.H. Overweight and obesity and factors associated with menopause. Cienc. Saude Coletiva 2016, 21, 1145-1156.
4. Round, J.L.; Mazmanian, S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat. Rev. Immunol. 2009, 9, 313-323.
5. Sanz, Y.; Santacruz, A.; Gauffin, P. Gut microbiota in obesity and metabolic disorders. Proc. Nutr. Soc. 2010, 69, 434-441.
6. Xu, J.; Gordon, J.I. Honor thy symbionts. Proc. Natl. Acad. Sci. USA 2003, 100, 10452-10459.
7. Miller, L.M.; Lampe, J.W.; Newton, K.M.; Gundersen, G.; Fuller, S.; Reed, S.D.; Frankenfeld, C.L. Being overweight or obese is associated with harboring a gut microbial community not capable of metabolizing the soy isoflavone daidzein to o-desmethylangolensin in peri- and post-menopausal women. Maturitas 2017, 99, 37-42.
8. Cox-York, K.A.; Sheflin, A.M.; Foster, M.T.; Gentile, C.L.; Kahl, A.; Koch, L.G.; Britton, S.L.; Weir, T.L. Ovariectomy results in differential shifts in gut microbiota in low versus high aerobic capacity rats. Physiol. Rep. 2015, 3, e12488.
9. Guadamuro, L.; Delgado, S.; Redruello, B.; Florez, A.B.; Suarez, A.; Martinez-Camblor, P.; Mayo, B. Equol status and changes in fecal microbiota in menopausal women receiving long-term treatment for menopause symptoms with a soy-isoflavone concentrate. Front. Microbiol. 2015, 6, 777.
10. Panda, A.K.; Chakraborty, D.; Sarkar, I.; Khan, T.; Sa, G. New insights into therapeutic activity and anticancer properties of curcumin. J. Exp. Pharmacol. 2017, 9, 31-45.
11. Egan, M.E.; Pearson, M.; Weiner, S.A.; Rajendran, V.; Rubin, D.; Glockner-Pagel, J.; Canny, S.; Du, K.; Lukacs, G.L.; Caplan, M.J. Curcumin, a major constituent of turmeric, corrects cystic fibrosis defects. Science 2004, 304, 600-602.
12. Bengmark, S. Curcumin, an atoxic antioxidant and natural nfkappab, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: A shield against acute and chronic diseases. J. Parenter. Enter. Nutr. 2006, 30, 45-51.
13. Punithavathi, D.; Venkatesan, N.; Babu, M. Protective effects of curcumin against amiodarone-induced pulmonary fibrosis in rats. Br. J. Pharmacol. 2003, 139, 1342-1350.
14. Duvoix, A.; Blasius, R.; Delhalle, S.; Schnekenburger, M.; Morceau, F.; Henry, E.; Dicato, M.; Diederich, M. Chemopreventive and therapeutic effects of curcumin. Cancer Lett. 2005, 223, 181-190.
15. French, D.L.; Muir, J.M. The ovariectomized, mature rat model of postmenopausal osteoporosis:An assessment of the bone sparing effects of curcumin. Phytomedicine 2008, 15, 1069-1078.
16. Kim, W.K.; Ke, K.; Sul, O.J.; Kim, H.J.; Kim, S.H.; Lee, M.H.; Kim, H.J.; Kim, S.Y.; Chung, H.T.; Choi, H.S. Curcumin protects against ovariectomy-induced bone loss and decreases osteoclastogenesis. J. Cell. Biochem. 2011, 112, 3159-3166.
17. Zhang, Z.G.; Bai, D.; Liu, M.J.; Li, Y.; Pan, J.H.; Liu, H.; Wang, W.L.; Xiang, L.H.; Xiao, G.G.; Ju, D.H. Therapeutic effect of aqueous extract from ecliptae herba on bone metabolism of ovariectomized rats. Menopause 2013, 20, 232-240.
18. Masella, A.P.; Bartram, A.K.; Truszkowski, J.M.; Brown, D.G.; Neufeld, J.D. Pandaseq: Paired-end assembler for illumina sequences. BMC Bioinform. 2012, 13, 31.
19. Caporaso, J.G.; Kuczynski, J.; Stombaugh, J.; Bittinger, K.; Bushman, F.D.; Costello, E.K.; Fierer, N.; Pena, A.G.; Goodrich, J.K.; Gordon, J.I.; et al. Qiime allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335-336.
20. Folwarczna, J.; Zych, M.; Trzeciak, H.I. Effects of curcumin on the skeletal system in rats. Pharmacol. Rep. 2010, 62, 900-909.
21. Cho, D.C.; Kim, K.T.; Jeon, Y.; Sung, J.K. A synergistic bone sparing effect of curcumin and alendronate in ovariectomized rat. Acta Neurochir. 2012, 154, 2215-2223.
22. Kozakowski, J.; Gietka-Czernel, M.; Leszczynska, D.; Majos, A. Obesity in menopause-Our negligence or an unfortunate inevitability? Przeglad Menopauzalny = Menopause Rev. 2017, 16, 61-65.
23. Zhang, Z.; Song, C.; Fu, X.; Liu, M.; Li, Y.; Pan, J.; Liu, H.;Wang, S.; Xiang, L.; Xiao, G.G.; et al. High-dose diosgenin reduces bone loss in ovariectomized rats via attenuation of the rankl/opg ratio. Int. J. Mol. Sci. 2014, 15, 17130-17147.
24. Al-Safi, Z.A.; Polotsky, A.J. Obesity and menopause. Best Pract. Res. Clin. Obstet. Gynaecol. 2015, 29, 548-553.
25. Ley, R.E.; Backhed, F.; Turnbaugh, P.; Lozupone, C.A.; Knight, R.D.; Gordon, J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA 2005, 102, 11070-11075.
26. Baker, J.M.; Al-Nakkash, L.; Herbst-Kralovetz, M.M. Estrogen-gut microbiome axis: Physiological and clinical implications. Maturitas 2017, 103, 45-53.
27. Turnbaugh, P.J.; Ley, R.E.; Mahowald, M.A.; Magrini, V.; Mardis, E.R.; Gordon, J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444, 1027-1031.
28. Martin, F.P.; Dumas, M.E.; Wang, Y.; Legido-Quigley, C.; Yap, I.K.; Tang, H.; Zirah, S.; Murphy, G.M.; Cloarec, O.; Lindon, J.C.; et al. A top-down systems biology view of microbiome-mammalian metabolic interactions in a mouse model. Mol. Syst. Biol. 2007, 3, 112.
29. Cui, C.; Shen, C.J.; Jia, G.; Wang, K.N. Effect of dietary bacillus subtilis on proportion of bacteroidetes and firmicutes in swine intestine and lipid metabolism. Genet. Mol. Res. 2013, 12, 1766-1776.
30. Koliada, A.; Syzenko, G.; Moseiko, V.; Budovska, L.; Puchkov, K.; Perederiy, V.; Gavalko, Y.; Dorofeyev, A.; Romanenko, M.; Tkach, S.; et al. Association between body mass index and firmicutes/bacteroidetes ratio in an adult ukrainian population. BMC Microbiol. 2017, 17, 120.
31. Parnell, J.A.; Reimer, R.A. Prebiotic fibres dose-dependently increase satiety hormones and alter bacteroidetes and firmicutes in lean and obese jcr:La-cp rats. Br. J. Nutr. 2012, 107, 601-613.
32. Armougom, F.; Raoult, D. Use of pyrosequencing and DNA barcodes to monitor variations in firmicutes and bacteroidetes communities in the gut microbiota of obese humans. BMC Genom. 2008, 9, 576.
33. Golubeva, A.V.; Crampton, S.; Desbonnet, L.; Edge, D.; O’Sullivan, O.; Lomasney, K.W.; Zhdanov, A.V.; Crispie, F.; Moloney, R.D.; Borre, Y.E.; et al. Prenatal stress-induced alterations in major physiological systems correlate with gut microbiota composition in adulthood. Psychoneuroendocrinology 2015, 60, 58-74.
34. Zinkernagel, M.S.; Zysset-Burri, D.C.; Keller, I.; Berger, L.E.; Leichtle, A.B.; Largiader, C.R.; Fiedler, G.M.; Wolf, S. Association of the intestinal microbiome with the development of neovascular age-related macular degeneration. Sci. Rep. 2017, 7, 40826.
35. Ohtani, M.; Garcia, A.; Rogers, A.B.; Ge, Z.; Taylor, N.S.; Xu, S.; Watanabe, K.; Marini, R.P.; Whary, M.T.; Wang, T.C.; et al. Protective role of 17 beta-estradiol against the development of Helicobacter pylori-induced gastric cancer in ins-gas mice. Carcinogenesis 2007, 28, 2597-2604.
36. Saqui-Salces, M.; Rocha-Gutierrez, B.L.; Barrios-Payan, J.A.; Ruiz-Palacios, G.; Camacho-Arroyo, I.; Gamboa-Dominguez, A. Effects of estradiol and progesterone on gastric mucosal response to early Helicobacter pylori infection in female gerbils. Helicobacter 2006, 11, 123-130.
37. Santos, A.M.; Lopes, T.; Oleastro, M.; Gato, I.V.; Floch, P.; Benejat, L.; Chaves, P.; Pereira, T.; Seixas, E.; Machado, J.; et al. Curcumin inhibits gastric inflammation induced by Helicobacter pylori infection in a mouse model. Nutrients 2015, 7, 306-320.
38. Khonche, A.; Biglarian, O.; Panahi, Y.; Valizadegan, G.; Soflaei, S.S.; Ghamarchehreh, M.E.; Majeed, M.; Sahebkar, A. Adjunctive therapy with curcumin for peptic ulcer: A randomized controlled trial. Drug Res. 2016, 66, 444-448.
39. Zaidi, S.F.; Yamamoto, T.; Refaat, A.; Ahmed, K.; Sakurai, H.; Saiki, I.; Kondo, T.; Usmanghani, K.; Kadowaki, M.; Sugiyama, T. Modulation of activation-induced cytidine deaminase by curcumin in Helicobacter pylori-infected gastric epithelial cells. Helicobacter 2009, 14, 588-595.
40. Foryst-Ludwig, A.; Neumann, M.; Schneider-Brachert,W.; Naumann, M. Curcumin blocks nf-kappab and the motogenic response in Helicobacter pylori-infected epithelial cells. Biochem. Biophys. Res. Commun. 2004, 316, 1065-1072.